Key result
Transcutaneous auricular vagus nerve stimulation fails to alter baroreflex sensitivity during orthostatic stress vs sham.
Why the study?
Baroreflex dysfunction and autonomic imbalance are key features of hypertension that current pharmacological treatments often fail to address.
Does transcutaneous auricular vagus nerve stimulation improve baroreflex sensitivity and heart rate variability during orthostatic stress in healthy normotensive adults?
RCT (n=32)
Single-blind
1:1 computer-based sequence, sequentially assigned
No
Does transcutaneous auricular vagus nerve stimulation improve baroreflex sensitivity and heart rate variability during orthostatic stress in healthy normotensive adults?
Acute transcutaneous auricular vagus nerve stimulation in healthy adults did not demonstrate a significant treatment-specific improvement in baroreflex sensitivity compared to sham, despite descriptive within-group increases in parasympathetic tone.
taVNS does not improve baroreflex sensitivity versus sham during orthostatic stress; challenges proposed autonomic benefits in healthy adults and leaves effects in disease open.
Baroreflex dysfunction and autonomic imbalance are key pathophysiological features of hypertension, but current pharmacological approaches often fail to address these neural mechanisms. This study investigated whether transcutaneous auricular vagus nerve stimulation (taVNS) enhances autonomic regulation during blood pressure perturbation. In a randomized, single-blind, sham-controlled, crossover design experiment, 32 normotensive adults received 60-min taVNS or sham condition. Blood pressure perturbation was induced with the head-up tilt test (supine–tilt–supine). Heart rate variability (HRV) was analyzed across all four phases (S-baseline, early-tilt, late-tilt, recovery), whereas baroreflex sensitivity (BRS) was analyzed only during the 10-minute tilt phase. taVNS significantly increased parasympathetic HRV parameters (SDNN, RMSSD, pNN30, pNN50, HF) across all phases. During tilt, BRS up- and down-slope values increased significantly, indicating enhanced inter-beat interval responsiveness to systolic pressure fluctuations. In contrast, the sham procedure yielded no consistent changes in HRV or significant BRS alterations during tilt. These findings suggest that taVNS augments vagal modulation and baroreflex responsiveness, not only at rest but also during orthostatic stress, supporting a physiological mechanism that is likely mediated by auricular branch of the vagus nerve– nucleus tractus solitarius pathways. Consequently, taVNS shows potential to modulate conditions involving autonomic dysregulation, such as hypertension, and further research involving patient cohorts and longitudinal study protocols is needed. Clinical Trial: The clinical trial described in this paper was registered at https://cris.nih.go.kr/cris/index/index.do under the registration number KCT0011752 (first trial registered 20/03/2026, retrospective registration).
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted an RCT in Healthy normotensive adults (n=32). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Sham stimulation was evaluated on Direct crossover comparison of pre-to-post changes in up-slope baroreflex sensitivity (BRS) during the 10-minute tilt phase (MD 1.46, 95% CI -1.32 to 4.24, p=0.302). Transcutaneous auricular vagus nerve stimulation did not significantly alter baroreflex sensitivity during orthostatic stress compared to sham stimulation (MD 1.46 ms/mmHg, p=0.302).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: